Treatment of white patches with 4 Unani formulations
- Conditions
- Health Condition 1: null- Vitiligo (Any type)
- Registration Number
- CTRI/2018/05/014096
- Lead Sponsor
- Director General CCRUM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 214
1. Patients with clinically diagnosed Vitiligo.
2. Age â?? 8 to 60 years
3. Either gender
4. With any duration of disease, site, extension and distribution of
lesions.
5. Willingness to give written consent form.
1. Patients with Hepato-renal, cardiac and pulmonary malfunction.
2. Patients on active Vitiligo treatment with other drugs/systems.
3. Subjects with other skin disease.
4. Subjects with known allergies
5. Subjects those who are unwilling to come for regular follow-ups for
the entire duration of study.
6. Non-co-operative patients.
Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response is assessed in the form of percentage <br/ ><br>and gradingTimepoint: Baseline, 1st month, 2nd month, 3rd month, 4th <br/ ><br>month, 5th month, 6th month, 7th month, 8th month, 10th month and 12th month
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil